SCHEMBL6708775

SCHEMBL6708775

CCN(CC)S(=O)(=O)c1ccc2onc(C(=O)Nc3ccc(Br)cc3-c3nnn[nH]3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.48
MAPT P10636 4/20 0.40
TP53 P04637 1/20 0.40
KMT2A Q03164 4/20 0.39
HPGD P15428 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 9/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 2/20 0.39
NR2F2 P24468 1/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 1/20 0.38
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPK1 P28482 1/20 0.37
MDM4 O15151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713596 0.91 RXFP1 (0.37) RXFP1MAPTKMT2AHPGDMEN1
SCHEMBL6711857 0.91 ALDH1A1 (0.46) RXFP1MAPTTP53KMT2AHPGD
SCHEMBL6708970 0.88 ALDH1A1 (0.44) RXFP1MAPTTP53KMT2AHPGD
SCHEMBL6707839 0.86 RXFP1 (0.49) RXFP1MAPTTP53KMT2AHPGD
SCHEMBL6710349 0.85 HIF1A (0.38) RXFP1MAPTKMT2AHPGDNPSR1
SCHEMBL6713461 0.82 GPR27 (0.39) RXFP1MAPTTP53KMT2ANPSR1
SCHEMBL6713150 0.82 HIF1A (0.43) RXFP1MAPTKMT2AHPGDNPSR1
SCHEMBL6833164 0.82 RXFP1 (0.54) RXFP1MAPTTP53KMT2AHPGD
SCHEMBL6709880 0.82 TNIK (0.35) RXFP1MAPTKMT2AHPGDNPSR1
SCHEMBL6707699 0.82 HIF1A (0.43) MAPTTP53KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 RXFP1 3836/4885MAPT 4754/4885TP53 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.